also go back over the 2021 AGM, or might be 2022. From memory DrT mentioned it work make sense to go through a list of cardiotoxic drugs from most toxic to least and determine if Bisantrene cardio protection works.
If we are now two years on, the extended collaboration was funded to address this. I am assuming Doan’s research paper is the fruit and it’s already done.
On the FTO front we are also forgetting Sheba 2 final results and Oncolines FTO analysis on the 143 cell lines. Lots behind the scenes that we don’t know and wont know until the right time. I am thinking P1 readouts H1 2025.
also go back over the 2021 AGM, or might be 2022. From memory...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $242.5M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.50 | $1.43 | $62.91K | 43.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5700 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 591 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.46 |
Change
-0.005 ( 0.23 %) |
||||
| Open | High | Low | Volume | ||
| $1.44 | $1.49 | $1.43 | 9034 | ||
| Last updated 13.08pm 24/05/2024 ? | |||||
| RAC (ASX) Chart |